Kalbe Farma Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Kalbe Farma

Kalbe Farma | Cash Flow

Fiscal year is January-December. All values IDR Millions.

2013

2014

2015

2016

2017

2018

Other Funds

3,635

34,122

44,902

1,583

16,538

72,212

Funds from Operations

954,916

2,325,242

2,513,238

2,233,387

2,079,548

2,842,988

Net Operating Cash Flow

954,916

2,325,242

2,513,238

2,233,387

2,079,548

2,842,988

Capital Expenditures

993,929

778,750

930,318

1,098,894

1,235,483

Sale of Fixed Assets & Businesses

28,053

40,268

16,063

89,565

57,678

Purchase/Sale of Investments

65,689

32,010

30,551

13,491

Net Investing Cash Flow

935,780

738,570

882,245

1,043,586

1,185,795

Cash Dividends Paid - Total

900,693

796,877

890,627

1,031,253

Issuance/Reduction of Debt, Net

309,619

293,325

98,573

94,077

72,404

Net Financing Cash Flow

587,439

1,124,325

836,957

986,287

975,387

Net Change in Cash

472,829

463,235

838,153

196,330

72,974

Free Cash Flow

39,013

1,574,536

1,609,496

1,194,336

915,713

Net Assets from Acquisitions

3,706

Other Sources

5,500

Exchange Rate Effect

95,474

888

44,117

7,185

8,660

Other Uses

35,593

About Kalbe Farma

View Profile

Address	Gedung KALBE Jakarta JK 10510 Indonesia
Employees	-
Website	http://www.kalbe.co.id
Updated	07/08/2019
PT Kalbe Farma Tbk engages in the development, production, distribution, and trade of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores throughout Indonesia.